Clinical Trial

Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

Study acronym: i-RTCT
Completed
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)
Protocol Amendment History 4 changes
critical Trial completed 2026-07-24
notable Enrollment reduced: 220 -> 136 participants 2026-07-24
notable Primary completion moved earlier: 2026-08-29 -> 2023-08-17 2026-07-24
minor Completion moved earlier: 2026-11-29 -> 2025-01-09 2026-07-24
Trial Details
NCT Number NCT03117946
Lead Sponsor Centre Hospitalier Universitaire de Besancon
Conditions Lung Cancer, Head and Neck Cancer
Enrollment 136 participants
Start Date 2017-05-29
Primary Completion 2023-08-17 (estimated)
Study Completion 2025-01-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-23